Assignee
NASTECH PHARM CO
US·21 granted patents·74 pending applications·581 citations·filing 1985–2009
Top patents by PatentIndex Score
95 records- 0195US7166575B2Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2002·Granted Jan 23, 2007·46 cites·19 claims
- 0293US7244709B2Compositions and methods for enhanced mucosal delivery of parathyroid hormoneNASTECH PHARM CO·Filed 2005·Granted Jul 17, 2007·26 cites·32 claims
- 0391US7157426B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jan 2, 2007·40 cites·19 claims
- 0488US6451848B1Compositions and methods comprising morphine gluconateNASTECH PHARM CO·Filed 2000·Granted Sep 17, 2002·27 cites·21 claims
- 0586US7863245B2Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesityNASTECH PHARM CO·Filed 2008·Granted Jan 4, 2011·6 cites·15 claims
- 0686US7186691B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2003·Granted Mar 6, 2007·22 cites·27 claims
- 0784US7229966B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jun 12, 2007·20 cites·41 claims
- 0884US6677346B1Methods comprising intranasal morphineNASTECH PHARM CO·Filed 2000·Granted Jan 13, 2004·33 cites·13 claims
- 0982US7186692B2Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Mar 6, 2007·15 cites·50 claims
- 1082US6436950B1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 1999·Granted Aug 20, 2002·46 cites·15 claims
- 1181US6599883B1Nasal delivery of xylitolNASTECH PHARM CO·Filed 1999·Granted Jul 29, 2003·58 cites·26 claims
- 1281US6225343B1Compositions and methods comprising morphine gluconateNASTECH PHARM CO·Filed 1999·Granted May 1, 2001·43 cites·37 claims
- 1379US7229636B1Cyanocobalamin low viscosity aqueous formulations for intranasal deliveryNASTECH PHARM CO·Filed 2004·Granted Jun 12, 2007·10 cites·31 claims
- 1479US4778810ANasal delivery of caffeineNASTECH PHARM CO·Filed 1987·Granted Oct 18, 1988·73 cites·8 claims
- 1577US6740660B2Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2002·Granted May 25, 2004·6 cites·12 claims
- 1676US4749700ANovel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing sameNASTECH PHARM CO·Filed 1987·Granted Jun 7, 1988·56 cites·19 claims
- 1769US2007155658A1Nanoparticles for delivery of nucleic acids and stable double-stranded rnaNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1868US2009274658A1Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic CompoundsNASTECH PHARM CO·Filed 2009·Application pending·0 cites
- 1965US2005136437A1Nanoparticles for delivery of nucleic acids and stable double-stranded RNANASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2064US7329725B1Phage displayed Trp cage ligandsNASTECH PHARM CO·Filed 2004·Granted Feb 12, 2008·0 cites·28 claims
- 2164US2006122137A15'-methylpyrimidine and 2'-O-methyl ribonucleotide modified double-stranded ribonucleic acid moleculesNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 2263US4624965ANovel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing sameNASTECH PHARM CO·Filed 1985·Granted Nov 25, 1986·30 cites·7 claims
- 2363US2004242626A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2463US2008113011A1Compositions and methods for enhanced mucosal delivery of interferon betaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 2563US2008261304A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 2663US2004204441A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2763US2004242625A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2861US2006160123A1Method of minimizing off-target effects of siRNA moleculesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 2961US2006210614A1Method of treatment of a metabolic disease using intranasal administration of exendin peptideNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3061US2007154449A1Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3160US2007244049A1Compositions and methods for enhanced mucosal delivery of parathyroid hormoneNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 3260US2005129679A1Method for opening tight junctionsNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 3360US2006142230A1Double-stranded ribonucleic acid molecules having ribothymidineNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 3458US2007129299A1Compositions and methods for enhanced mucosal delivery of pyy peptideNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3558US2007275893A1Compositions for enhanced epithelial permeation of peptide yy for treating obesityNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3658US2007197437A1Compositions for enhanced epithelial permeation of y2 receptor-binding peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3757US2007185035A1Enhanced mucosal administration of neuroprotective peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3857US2006003989A1Compositions and methods using acetylcholinesterase (ACE) inhibitors to treat central nervous system (CNS) disorders in mammalsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 3957US2005143303A1Intranasal administration of glucose-regulating peptidesNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4056US2004258663A1Compositions and methods for enhanced mucosal delivery of interferon alphaNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4156US2007213257A1Compositions and methods for complexes of nucleic acids and peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4256US2007293449A1Compositions and methods for delivery of double-stranded rnaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4356US2007173447A1Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agentNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4456US2008234200A1Method of treatment of a metabolic disease using intranasal administration of exendin peptideNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 4556US2007213293A1Rnai therapeutic for respiratory virus infectionNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4656US2007077283A1Method of enhancing transmucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4756US2008119408A1Pth formulations for intranasal deliveryNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4855US2004242624A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4955US2007172430A1Dry powder compositions for rna influenza therapeuticsNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 5055US2004248846A1Intranasal administration of triptansNASTECH PHARM CO·Filed 2004·Application pending·0 cites
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NASTECH PHARM CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →